Office for Research Affairs (ORA) Newsletter
Section 1 – What’s New
Section
2 – New Funding Opportunities
Section 3– Conferences
Section 4 – Reminders
Section
5 – Closing Information and Unsubscribe Instructions
1.
Health
Science News & Communications- May 1, 2002: "UF
Researchers to Test Chemotherapy drug for treating severe brain injuries"
(Posted 08/02/02)
2. Health
Science News & Communications- July 19, 2002: "UF's
Wharton Honored for Pediatrics Work" (Posted
08/02/02)
3. New
Research Administrators Training Series
If
you are a faculty or staff member at the University of Florida interested
in more thoroughly understanding research and sponsored programs management,
this series is for you!
Starting
with Departmental Administrators
101, this new Research Administrators Training Series will continue throughout
2002-2003 with two certificate of completion programs. Workshops in these
programs are taught by UF experts and include such topics as proposal processing
and review, building a budget that survives the real world, and post-award
contract and grants administration. The
goals of this training series are to: ->Identify
and maintain a trained workforce in research administration to support UF's
academic mission ->Develop
a consistent, standardized body of knowledge for UF research administrators
->Establish
high performance standards for research administrators at UF Provide knowledge
and support of faculty in the management of their research endeavors ->Provide
knowledge and support of faculty in the management of their research endeavors
This
series is the result of coordinated efforts from throughout the UF campus,
including the Office of Research and Graduate Programs, Finance and Accounting's
Contracts & Grants, IFAS Sponsored Programs, Office of Engineering Research,
Human Resources' Training & Development, the College of Liberal Arts and
Sciences, and the College of Medicine. Don't
miss our kick-off session! Register
online today for Departmental Administrators 101. 4.
From FYI:
NSF: Proposals
Must Address Merit Review Criteria or They Will Be Returned
In 1997 the
National Science Board approved the use of two merit review criteria, and
since then has continued to emphasize the importance of broader impacts in
the preparation and review of proposals submitted to NSF. Effective
October 1, 2002, NSF will return without review
proposals that do not separately address both merit review criteria within
the Project Summary. NSF believes that these changes to the proposal
preparation and processing guidelines will more clearly articulate the importance
of broader impacts to NSF-funded projects. 5.
From
FYI: UF
Task Force on Bioterrorism Seeks Interest/Information for Future Grant Applications
The
UF Task Force on Bioterrorism is establishing a data file containing ongoing
projects and faculty expertise in any area related to bioterrorism and emerging
infectious diseases. This is part of the planning stage prior to submitting
grant applications to federal agencies for new funds for projects in this
area. Such projects will be multidisciplinary over a broad range of disciplines
and could include faculty and projects from virtually any college.
Please
send a short description (1-2 paragraphs) of your project/expertise, as well
as contact information (name, departmental affiliation, e-mail, phone university
address) to Dr. Richard Gutekunst at Rgutekun@vpha.health.ufl.edu
(Posted 08/02/02)
6.
NIH
Guide: INCLUSION
OF ADDITIONAL RECEIPT DATES FOR EXPLORATORY/DEVELOPMENTAL GRANTS FOR DIAGNOSTIC
CANCER IMAGING (PA-01-030) For
this PA, applications will also be received on February 1, 2003, and June
1, 2003. This
PA can be accessed at the following URL:
http://grants.nih.gov/grants/guide/pa-files/PA-01-030.html. 1.
Pfizer
- "Pfizer
Visiting Professorship Program in Infectious Diseases" - September
6, 2002 (Internal
Deadline) ; October 1, 2002 (Application
Deadline). (Posted 08/02/02)
2. Pfizer
- "Pfizer
Visiting Professorship Program in Cardiovascular Disease" - September
6, 2002 (Internal
Deadline); September 30, 2002 (Application
Deadline). (Posted 08/02/02)
For
additional funding opportunities: Research and Graduate Programs FYI http://rgp.ufl.edu/fyi/
New
Funding Opportunities are posted at http://www.med.ufl.edu/research/fundopps.html.
New
NIH notices, requests for applications and program announcements can be
found at
NIH Notice
1. A
Clobal Perspective of Researh Administration
The Society
of Research Administrators
International is hosting their 2002 Annual Meeting. The meeting will be
held Oct. 26-30, 2002, at the Rosen
Centre Hotel in Orlando, FL.
Click
here to download a printable registration form. (Posted
08/02/02)
1. The
Burroughs Welcome Fund is requesting applications for the Clinical
Scientist Awards in Translational Research. Applications
are due to ORA by 08/05/02 for an Internal
Competition.
2. Pfizer
is requesting applications for the 2002
Pfizer Visiting Professorship Program in Pediatrics. Applications
are due to ORA by 08/09/02 for an Internal
Competition.
3. The
Robert Wood Johnson Foundation is requesting applications for the
Promoting
Palliative Care Excellence in Intensive Care. Applications
are due to ORA by 08/09/02 for an Internal
Competition.
4. The American
Society of Hematology is requesting applications for the 2002
ASH Scholar Awards. Applications are due to ORA by 08/09/02
for an Internal
Competition.
Please send any comments or suggestions
about this newsletter to Aundrea Corbit “SUGGESTIONS”.
If
you do not want to receive any more issues, please reply to Aundrea
Corbit with "UNSUBSCRIBE"
in the subject line or body of the email.
(Posted
08/02/02)
In an effort to increase compliance with these requirements, the January 2002
issuance of the Grant Proposal Guide incorporated revised proposal preparation
guidelines relating to the development of the Project Summary and Project
Description. The GPG now specifies that Principal Investigators must address
both merit review criteria in separate statements within the one-page Project
Summary. The GPG also reiterates that broader impacts resulting from the proposed
project must be addressed in the Project Description and described as an integral
part of the narrative. In addition, the FastLane system has been enhanced
to remind/inform PIs of the new proposal preparation requirements. There is
also increased coverage of these requirements on the NSF website.
(Posted 08/02/02)
If you have funded or even unfunded projects related to this area or particular
expertise that could apply to bioterrorism and/or emerging infectious diseases,
please reply to this message within 2 weeks of receiving it. Of special interest
are technologies for early detection, animal health, insect vectors, the safety
of food and water supplies, vaccines, human pathogens, new antimicrobials,
psychological responses to terror, public health education, and human interface
with prevention/ detection/ response techniques and technology. However, this
is not an exclusive list.
The National Cancer Institute wishes to give a notice of inclusion of additional
receipt dates for applications submitted in response to PA- 01-030: EXPLORATORY/DEVELOPMENTAL
GRANTS FOR DIAGNOSTIC CANCER IMAGING. This PA appeared in the December 8,
2000 issue of the NIH Guide for Grants and Contracts.
(Posted 08/02/02)